Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Miklos Rohla

Showing results (31-40 of 50) with videos related to

Pageof 5
Sort By:
European Heart Journal. Acute Cardiovascular Care|February 19, 2016
Clinical predictors of patient related delay in the VIENNA ST-elevation myocardial infarction network and impact on long-term mortalityBernhard Jäger, Serdar Farhan, Miklos Rohla, et al.
Plos One|June 21, 2017
Contemporary use of P2Y12-inhibitors in patients with acute coronary syndrome undergoing percutaneous coronary intervention in Austria: A prospective, multi-centre registryMaximilian Tscharre, Florian Egger, Matthias Machata, et al.
American Heart Journal|May 16, 2023
Ultrathin-strut vs thin-strut drug-eluting stents for multi and single-stent lesions: A lesion-level subgroup analysis of 2 randomized trialsJonas D Häner, Miklos Rohla, Sylvain Losdat, et al.
Heart Rhythm|July 19, 2014
High-degree atrioventricular block in patients with preexisting bundle branch block or bundle branch block occurring during transcatheter aortic valve implantationFlorian Egger, Michael Nürnberg, Miklos Rohla, et al.
International Journal of Cardiology|July 9, 2016
Endpoint design for future renal denervation trials - Novel implications for a new definition of treatment response to renal denervationThomas Lambert, Alexander Nahler, Miklos Rohla, et al.
European Heart Journal. Acute Cardiovascular Care|March 30, 2023
Clinical outcomes in ST-segment elevation myocardial infarction patients undergoing percutaneous coronary interventions later than 48 h after symptom onsetMiklos Rohla, Fabrice Temperli, George C M Siontis, et al.
Journal of the American Heart Association|April 26, 2025
Clinical Outcomes in Patients With Acute Pulmonary Embolism Undergoing Ultrasound-Assisted Catheter-Directed ThrombolysisDominik F Draxler, Judith Karen Johannes, Masaaki Nakase, et al.
JACC. Cardiovascular Interventions|January 10, 2024
Pretreatment With P2Y<sub>12</sub> Inhibitors in ST-Segment Elevation Myocardial Infarction: Insights From the Bern-PCI RegistryMiklos Rohla, Shirley Xinyu Ye, Hiroki Shibutani, et al.
International Journal of Cardiology|May 1, 2018
Heart failure subtypes and thromboembolic risk in patients with atrial fibrillation: The PREFER in AF - HF substudyJolanta M Siller-Matula, Ladislav Pecen, Giuseppe Patti, et al.
Plos One|August 17, 2016
Effects of Renal Denervation Documented in the Austrian National Multicentre Renal Denervation RegistryDavid Zweiker, Thomas Lambert, Clemens Steinwender, et al.
Pageof 5

Showing results (31-40 of 50) with videos related to

Sort By:
Pageof 5
European Heart Journal. Acute Cardiovascular Care|February 19, 2016
Clinical predictors of patient related delay in the VIENNA ST-elevation myocardial infarction network and impact on long-term mortalityBernhard Jäger, Serdar Farhan, Miklos Rohla, et al.
Plos One|June 21, 2017
Contemporary use of P2Y12-inhibitors in patients with acute coronary syndrome undergoing percutaneous coronary intervention in Austria: A prospective, multi-centre registryMaximilian Tscharre, Florian Egger, Matthias Machata, et al.
American Heart Journal|May 16, 2023
Ultrathin-strut vs thin-strut drug-eluting stents for multi and single-stent lesions: A lesion-level subgroup analysis of 2 randomized trialsJonas D Häner, Miklos Rohla, Sylvain Losdat, et al.
Heart Rhythm|July 19, 2014
High-degree atrioventricular block in patients with preexisting bundle branch block or bundle branch block occurring during transcatheter aortic valve implantationFlorian Egger, Michael Nürnberg, Miklos Rohla, et al.
International Journal of Cardiology|July 9, 2016
Endpoint design for future renal denervation trials - Novel implications for a new definition of treatment response to renal denervationThomas Lambert, Alexander Nahler, Miklos Rohla, et al.
European Heart Journal. Acute Cardiovascular Care|March 30, 2023
Clinical outcomes in ST-segment elevation myocardial infarction patients undergoing percutaneous coronary interventions later than 48 h after symptom onsetMiklos Rohla, Fabrice Temperli, George C M Siontis, et al.
Journal of the American Heart Association|April 26, 2025
Clinical Outcomes in Patients With Acute Pulmonary Embolism Undergoing Ultrasound-Assisted Catheter-Directed ThrombolysisDominik F Draxler, Judith Karen Johannes, Masaaki Nakase, et al.
JACC. Cardiovascular Interventions|January 10, 2024
Pretreatment With P2Y<sub>12</sub> Inhibitors in ST-Segment Elevation Myocardial Infarction: Insights From the Bern-PCI RegistryMiklos Rohla, Shirley Xinyu Ye, Hiroki Shibutani, et al.
International Journal of Cardiology|May 1, 2018
Heart failure subtypes and thromboembolic risk in patients with atrial fibrillation: The PREFER in AF - HF substudyJolanta M Siller-Matula, Ladislav Pecen, Giuseppe Patti, et al.
Plos One|August 17, 2016
Effects of Renal Denervation Documented in the Austrian National Multicentre Renal Denervation RegistryDavid Zweiker, Thomas Lambert, Clemens Steinwender, et al.
Pageof 5